翔豐華(300890.SZ):常州武嶽峯11月18日以來共減持1.10%股份
格隆匯11月30日丨翔豐華(300890.SZ)公佈,公司現收到常州武嶽峯創業投資合夥企業(有限合夥)的通知,自2021年11月18日-11月29日期間,常州武嶽峯創業投資合夥企業(有限合夥)通過大宗交易方式合計減持公司股份110萬股,佔公司總股本的1.10%。截至該公吿日,其披露的股份減持計劃減持數量已達3.30%。
常州武嶽峯創業投資合夥企業(有限合夥)當前持有公司股份468.7392萬股,佔公司總股本的4.69%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.